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Ubiquitin (Ub), a protein consisting of 76 amino acid resi-
dues which is present in all eukaryotic cells tested (Rech-
steiner, 1987), plays a role in the degradation of abnormal
and short-lived proteins by the ATP- and Ub-dependent
proteolytic systems (Hershko et al., 1980). Ubiquitination of
histone 2A varies during the course of the cell cycle (Matsui
et al., 1979). Accumulation of Ub has been shown
immunohistochemically in intracellular inclusions in several
diseases, including neurofibrillary tangles and senile plaques
of Alzheimer's disease, Lewy bodies of Parkinson's disease,
Pick bodies of Pick's disease, Rosenthal fibres within astro-
cytes, Mallory bodies of alcoholic liver disease, and Lewy
body-like hyaline inclusions of familial amyotrophic lateral
sclerosis (Mori et al., 1987; Perry et al., 1987; Lowe et al.,
1988; Murayama et al., 1989). Ub has been considered to
play a role in pathological processes of these diseases.
Recently, Galloway and Likavec (1989) have shown the exist-
ence of intense Ub immunoreactivity in perikarya of neo-
plastic astrocytes but not in normal astrocytes. However, the
reason for why accumulation of Ub was found only in
malignant astrocytes, is unclear. Ub immunoreactivity in
other malignant tissues has not been investigated. In this
Table I Ubiquitin immunoreactivity in malignant tumours
No. positivel
Tumours no. ofcases Intensitya
Lung
Adenocarcinoma
Squamous cell carcinoma
Adenosquamous carcinoma
Adenoid cystic carcinoma
Small cell carcinoma
Large cell carcinoma
Heterotopic choriocarcinoma
Carcinoid
Liver
Hepatocellular carcinoma
Pancreas
Adenocarcinoma
Carcinoid
Prostate
Adenocarcinoma
Stomach
Well and moderately differentiated
adenocarcinoma
Signet ring cell carcinoma and poorly
differentiated adenocarcinoma
Colon
Adenocarcinoma
Gall bladder
Adenocarcinoma
Thyroid
Papillary adenocarcinoma
Ovary
Mucinous adenocarcinoma
Kidney
Renal cell carcinoma
8/8
1/1
1/1
1/1
1/1
3/3
1/1
1/1
6/6
3/3
2/2
3/3
4/7
3/3
2/5
2/4
1/2
1/2
(l/
+ + +
+
+
++
++
+
+ +
+ ++
+ ++
+ +
+ ++
++
+ ++
_ +
U/II
aIntensity is assessed as negative (-), weakly positive ( + ), or
strongly positive ( + + ).
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study, Ub immunoreactivity was studied in various malignant
tumours in humans.
A total of 55 cases of primary malignant tumour from
various organs were available for study, including lung, liver,
pancreas, prostate, stomach, colon, gall bladder, thyroid
gland, ovary and kidney (Table I). Nonmalignant tissues,
which were microscopically normal tissues adjacent to the
tumour or normal tissues (lung, liver, stomach and kidney)
from patients without history of cancer were also investigated
(Table II). These tissues were obtained either at the time of
surgery or at autopsy within 2 h of death. All tissues were
fixed with 10% buffered formalin, and embedded in paraffin
by conventional method. Five-micrometer sections of each
specimen were stained immunohistochemically. Slides of each
adjacent section were stained with hematoxylin and eosin.
Antibodies against Ub were prepared according to the
method of Haas and Bright (1985) with some modifications.
Ub (Sigma, MO, USA) was conjugated to bovine serum
albumin (BSA) (Fr. V. Sigma) via glutaraldehyde for antigen
preparation. Three rabbits were immunised by intradermal
injection of the conjugate. Antisera were collected and dia-
lysed against 0.01 M phosphate buffered saline (PBS). The
antibody to Ub was purified by affinity chromatography on
Ub-coupled Affi-Gel 10 (Bio-Rad, Richmond, USA). The
specificity of the antibody was examined by the method of
Meyer et al. (1986) using ATP-depleted rabbit reticulocyte
fraction II prepared as described previously (Hershko et al.,
1983). Purified Ub-(2 tg ml-') coated enzyme-linked immuno-
sorbent assay (ELISA), as well as sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS PAGE)-immunoblot
Table II Ubiquitin immunoreactivity in nonmalignant tissuesa
No. positive!
Tissues no. ofcases Intensityb
Lung
Alveolar epithelium 0/18
Bronchial epithelium 18/18 +
Liver
Hepatic cell 0/6
Bile duct 6/6 +
(Mallory body) (1/1) (+ +)
Pancreas
Acinar cell 0/5
Duct 5/5 +
Langerhans's island 0/5
Prostate 0/3
Stomach
Surface epithelial cell 5/7 - - +
Gastric gland 0/7
Colon and small intestine
Intestinal epithelium 3/6 - + +
Ganglion in myenteric plexus 3/3 + +
Gall bladder
Epithelium 2/4 - +
Thyroid 0/2
Ovary 0/2
Kidney
Proximal and distal tubulus 0/2
Collecting tubulus 2/2 +
Glomerulus 0/2
aTissues obtained in area adjacent to tumour or atautopsy.bIntensity
is assessed as negative (-), weakly positive ( + ), or strongly positive
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analysis (Towbin et al., 1979) of purified Ub and histones
were used to verify antigen-specificity.
Tissue sections were treated with 0.3% H202 in PBS at
room temperature for 15 min for blocking the activity of
endogenous peroxidase. After rinsing in PBS, the sections
were treated with 10% normal swine serum in 1% BSA-PBS
at room temperature for 20 min. Then, the sections were
incubated with antibody to Ub (0.5 yg ml - immunoglobulin
with 1% BSA-PBS) overnight at 4°C. Nonimmune rabbit
serum (diluted 1:100 with 1% BSA-PBS) was used as a
control. After rinsing, the slides were incubated with bio-
tinylated swine anti-rabbit IgG (diluted 1:500 in 1% BSA-
PBS, Dakopatts, Denmark) for 60 min, followed by 60min
incubation with a 1:100 dilution of streptavidin-biotin peroxi-
dase complex (Dakopatts). The binding of peroxidase was
visualised using the 3,3-diaminobenzidine/H202 reaction.
Only tissues which showed specific reaction against anti-Ub
antibody in both the nuclei and the cytoplasms were judged
to be positive. The intensity of staining was assessed as
negative (-), weakly positive ( + ), or strongly positive
(+ +)-
The affinity-purified antibody to Ub bound to many pro-
teins in the rabbit reticulocyte fraction II treated with ATP,
but to few in fraction II not treated with ATP (Figure 1).
Since Ub is conjugated to acceptor proteins in fraction II
only in the presence of ATP (Haas & Bright, 1985; Meyer et
al., 1986), the antibody can be directed to Ub-protein con-
jugates, as well as to Ub. This antibody also detected purified
Ub and ubiquitinated histone in SDS-PAGE immunoblot,
and reacted to Ub fixed on the ELISA plate at a concentra-
tion less than 1 jig ml-' immunoglobulin (data not shown).
In these results, the affinity-purified antibody to Ub was
found to be specific to Ub and Ub-protein conjugates.
The reactivity of antibody against Ub in malignant
tumours and nonmalignant tissues from various organs is
demonstrated in Tables I and II. Control slides did not show
specific reaction in either nuclei or cytoplasms. The immuno-
reactive Ub was detectable in the majority of malignant
tumours (Table I). Anti-Ub antibody was reactive to tumour
cells in all cases of lung cancer, hepatocellular carcinoma,
pancreatic carcinoma and prostatic carcinoma (Figures 2 and
3). All of the tumour cells with positive reactions showed
diffuse, homogeneous staining. Carcinoid showed strong
( + +) staining in the cytoplasms. In the stomach, diffuse
positive staining was observed in 7/10 of tumour tissues
(Figure 4). A relationship between cellular reactivity with the
antibody to Ub and the degree of histological differentiation
was not noted. A part of tumour cells derived from other
tumours showed weak ( +) staining (Table I).
Most nonmalignant tissues were not immunoreactive to
anti-Ub antibody, but a few showed positive staining (Table
II). Ganglion cells in myenteric plexus of the intestinal tract
showed strongly positive (+ +) staining in the cytoplasm.
Epithelial cells of the bile duct, pancreatic duct, stomach,
intestinal tract, gall bladder, bronchi and collecting tubuli of
the kidney were positively stained, showing a range of re-
activity from + to + + . Mallory bodies in fatty liver, were
particularly stained (+ +).
This is the first immunohistochemical study on the localis-
ation of Ub in various malignant tissues. The results indicate
that Ub or ubiquitinated proteins accumulated in the major-
ity of malignant tumour cells with various degrees of inten-
sity. The Ub immunoreactivity was distributed uniformly in
the nuclei and cytoplasms of malignant cells regardless of
degree of differentiation or origin of tumour.
Since Ub is a heat shock protein (Bond & Schlesinger, 1985, 1986) and polyubiquitin gene expression is a cytopro- tective phenomenon (Finley et al., 1987), the enhancement of
Ub immunoreactivity in the tumour cells may be a kind of
stress responses induced by variuos host defence mechanisms
and anticancer treatments. In view of a good correlation
between the level of heat shock proteins and thermotolerance
in mammalian cells (Landry et al., 1982; Li & Werb, 1982) or
in tumour cells (Li & Mak, 1985), the increased levels of Ub
in tumour cells might reflect their abilities of resistance to
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Figure 1 Detection of ubiquitin-immunoreactive proteins with
antibody to ubiquitin. ATP-depleted reticulocyte fraction II was
prepared from rabbit reticulocytes treated with 2,4-dinitrophenol
and 2-deoxyglucose (Hershko et al., 1983). Fraction II was
incubated with ubiquitin with (lane 2) or without (lane 1) ATP
(Meyer et al., 1986). Samples (40 1tg fraction II proteins/lane)
were electrophoresed on 10% SDS PAGE gel, transferred onto
PVDF filter (Millipore), and then immunostained.
Figure 2 Adenocarcinoma of the lung was strongly stained for
ubiquitin antibody. Normal bronchial epithelium was weakly
stained ( x 80, ABC method).
Figure 3 Cytoplasms of hepatocellular carcinoma cells showed
intensive staining for ubiquitin antibody. Adjacent normal hepa-
tic cells in the pseudolobule were not stained ( x 25, ABC
method).
anticancer treatment. We also observed varied intensity of
Ub immunoreactivity among various origin of tumours
(Table I), but in this study it may be too early to conclude
the relationship between the level of Ub and some physio-
logical states of the tumour cells. Apart from the stress
responses, the enhancement of Ub immunoreactivity in
tumours might be due to the higher metabolic/catabolic ratio
of the tumours vs normal tissues. Accumulation of neoplastic
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cell-specific ubiquitinated proteins might be also one of the
explanations for the enhancement of Ub immunoreactivity.
Alternation of Ub levels, ubiquitinated histone and other
ubiquitinated proteins have also been observed during
development and differentiation (Goldknopf et al., 1980;
Wunsch et al., 1987; Agell & Mezquita, 1988). However, it is
difficult to assume common roles of Ub or ubiquitinated
proteins in the process of development, differentiation and
oncogenesis of the cells.
We observed positive immunoreactivity not only in malig-
nant tissues but also in the surface epithelia of the stomach,
intestine, gall bladder, bile duct, pancreatic duct and bronchi.
The increase of Ub immunoreactivity in these tissues might
be related to the stress response or cell turnover.
Our findings indicate that the Ub accumulation is one of
the properties of malignant tumours, though it is unknown
whether the Ub system plays roles for carcinogenesis and
tumour cell growth. Further characterisation of Ub immuno-
reactivity in tumour cells is required to elucidate these prob-
lems.
This work was supported by grants from Tokyo Biochemical
Research Foundation and the Ministry of Education, Science and
Culture, Japan.
Figure 4 Well-differentiated adenocarcinoma of the stomach
showed strong staining for ubiquitin antibody (x 40, ABC
method).
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